Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Adding MYC/BCL2 double expression to NCCN-IPI may not improve prognostic value to an acceptable level ; volume:59 ; number:1 ; day:19 ; month:2 ; year:2024 ; pages:1-7 ; date:12.2024
Blood research ; 59, Heft 1 (19.2.2024), 1-7, 12.2024
- Creator
-
Warnnissorn, Naree
Kanitsap, Nonglak
Niparuck, Pimjai
Boonsakan, Paisarn
Kulalert, Prapasri
Limvorapitak, Wasithep
Bhoopat, Lantarima
Saengboon, Supawee
Suriyonplengsaeng, Chinnawut
Chantrathammachart, Pichika
Puavilai, Teeraya
Chuncharunee, Suporn
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s44313-024-00006-w
- URN
-
urn:nbn:de:101:1-2404301038460.310054575420
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Warnnissorn, Naree
- Kanitsap, Nonglak
- Niparuck, Pimjai
- Boonsakan, Paisarn
- Kulalert, Prapasri
- Limvorapitak, Wasithep
- Bhoopat, Lantarima
- Saengboon, Supawee
- Suriyonplengsaeng, Chinnawut
- Chantrathammachart, Pichika
- Puavilai, Teeraya
- Chuncharunee, Suporn
- SpringerLink (Online service)
Other Objects (12)
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
Adding insult to injury
Adding Spirit to Economics
Adding to the List
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Adding performance counters to htop
Adding value to university collections
Adding Position Structures to Katja
Adding priority to event structures
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
Adding insult to injury
Adding Spirit to Economics
Adding to the List
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Adding performance counters to htop
Adding value to university collections
Adding Position Structures to Katja
Adding priority to event structures
Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement
Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors
Adding insult to injury
Adding Spirit to Economics
Adding to the List
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Adding performance counters to htop
Adding value to university collections
Adding Position Structures to Katja